Nucleotide-binding properties of kinase-deficient epidermal-growth-factor-receptor mutants

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Signaling

Background:

• The epidermal growth factor receptor (EGF-R) is a key regulator of cell growth and differentiation.
• Dysregulation of EGF-R activity is implicated in various cancers.
• Understanding the molecular mechanisms of EGF-R kinase activity is crucial for targeted therapies.

Purpose of the Study:

• To investigate the nucleotide-binding properties of wild-type EGF-receptor protein tyrosine kinase (PTK) and its mutants.
• To determine how specific amino acid substitutions affect ATP binding and kinase activity.
• To elucidate the mechanism by which kinase-inactivating mutations inhibit EGF-R function.

Main Methods:

• Utilized a fluorescence competition assay with the nucleotide analogue 2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate.
• Determined binding affinities for Adenosine Triphosphate (ATP) and Manganese-ATP (Mn.ATP) complex.
• Analyzed the PTK domains of wild-type EGF-R and two mutant proteins with site-specific amino acid substitutions.

Main Results:

• Mutation of the conserved Lys-721 residue did not abolish ATP and Mn.ATP binding, though Mn.ATP binding affinity was reduced.
• A second kinase-inactivating mutation at Asp-813 showed minimal effect on nucleotide-binding properties.
• These findings suggest that the primary impact of these mutations is not on nucleotide binding itself.

Conclusions:

• Kinase-inactivating mutations in EGF-receptor PTK, specifically at Lys-721 and Asp-813, do not prevent nucleotide binding.
• The observed inhibition of kinase activity stems from a disruption of the phospho-transfer reaction, not impaired nucleotide accessibility.
• These insights are vital for understanding EGF-R regulation and developing effective cancer treatments.